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Insulin Degradation by Adipose Tissue
STUDIES AT SEVERAL LEVELS OF CELLULAR ORGANIZATION
Barry J. GOLDSTEIN and James N. LIVINGSTON
Departments ofBiochemistry and Medicine, University of Rochester School ofMedicine,
Rochester, NY 14642, U.S.A,

(Received 1O August 1979)
A systematic study of the degradation of physiological concentrations of 125I-labelled
insulin was performed in intact fat-pads, isolated adipocytes and subcellular fractions of
isolated adipocytes. The findings indicate that insulin is rapidly degraded to low-molecular-weight peptides and/or amino acids by the intact tissue and isolated cells. Of the
total insulin-degradation products present after incubation with an intact fat-pad, 94% is
recovered in the medium, indicating that these products are not retained by the cells or
tissue. The plasma membranes do not degrade insulin significantly in the absence of
reduced glutathione, and over 99% of the cellular degradative capacity is found in the
postmicrosomal supernatant (cytosol). The cytosol degrades insulin to several labelled
fragments that are intermediate in size between insulin and insulin A chain, as well as to
the low-molecular-weight tissue degradation products. Inclusion of plasma membranes
with cytosol accelerates the cleavage of the intermediate fragments to the size of the
small products seen with the intact tissue. However, plasma membranes do not increase
the initial step in the degradation of insulin when incubated with cytosol, suggesting that
the insulin receptor is not involved with the direct cleavage of insulin. This study
supports the hypothesis that the bulk of insulin degradation occurs in the adipocyte
cytosol, where intermediate-sized fragments are generated and rapidly cleaved to smaller
products by the plasma membrane and quickly released into the surrounding medium.

The degradation of insulin is one consequence of
the interaction(s) between the hormone and a target
cell (Freychet et al., 1972; Gammeltoft & Gliemann,
1973; Terris & Steiner, 1975). Although this process
has long been recognized and studied in many
different tissues (for a review see Izzo, 1975), only
recently have attempts been made to link the events
in degradation with those responsible for eliciting
hormonal effects. Impetus for seriously considering
this possible relationship comes from the demonstrations that insulin is internalized by target cells
(Gorden et al., 1978), and that insulin degradation
may be related either directly or indirectly to
insulin-receptor association (Terris & Steiner, 1975;
Gliemann & Sonne, 1978), the initial step in insulin
action (Kahn, 1976). Moreover, the persistent failure
to identify a second messenger that helps mediate the
actions of insulin has also stimulated attempts to

Vin,*

Abbreviations used: VO,
VA and Vi, the gelfiltration elution volumes for Blue Dextran, insulin, insulin
A chain and the column internal volume respectively;
GSH, reduced glutathione.
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show that insulin fragments are intracellular
mediators of insulin action (Fujino et al., 1977).
The adipocyte represents a suitable insulin target
cell to investigate the process of insulin degradation
and its relevance to insulin action. With this cell, it is
possible to examine several aspects of insulin action
[e.g. association of insulin with the insulin receptor
(Gliemann et al., 1975), the stimulation of glucose
transport and metabolism, as well as effects on other
cellular systems (Minemura et al., 1970; Livingston
& Lockwood, 1975; Czech, 1976)], while monitoring the destruction of the hormone. Although
insulin degradation by adipose tissue has been previously studied (Rudman et al., 1966; Hammond &
Jarett, 1975; Sumner & Doisy, 1970), in general
very little is known of the specific physiological
events that operate to destroy the hormone. Without
this information it is not possible to judge if products
of degradation are involved in producing some otI the
cellular effects of insulin.
In the present work, insulin degradation was
studied at physiological hormone concentrations in a
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systematic manner by using intact fat-pads, isolated
adipocytes, and subcellular fractions of isolated
adipocytes. The results of these studies suggest that
insulin degradation is an ordered process, with most
of the initial degradation occurring in the cytoplasm. The plasma membranes act to accelerate
further degradation of insulin fragments generated in
the cytosol to amino acids and/or small peptides,
which are rapidly ejected from the cell.
Experimental
Animals
Male Sprague-Dawley rats weighing 220-240g
were obtained from Charles River Laboratories.

Materials
Na125I was purchased from New England Nuclear. Porcine insulin was a gift from the Eli Lilly Co.
Bio-Gel P-10 (100-200 mesh) was obtained from
Bio-Rad Laboratories. Oxidized insulin A chain,
cytochrome c (type VI), NADH, ATP, Ficoll (type
400DL) and Blue Dextran were purchased from
Sigma Chemical Co. Anti-[guinea-pig immunoglobulin G (goat)] and anti-[bovine insulin (guinea pig)]
sera were obtained from Miles Laboratories.
Dialysis tubing (type H47) and silicone oil were purchased from Arthur H. Thomas Co., Philadelphia,
PA, U.S.A. Collagenase (type I) was supplied by
Worthington, and bovine serum albumin (fraction
V) was obtained from Reheis Chemical, Phoenix,
AZ, U.S.A. Sucrose (ultrapure) was a product from
Schwarz/Mann. All other materials used were of
reagent grade.
Methods
Preparation of 125I-labelled insulin. 125I-labelled
insulin was prepared by the chloramine-T method to
a specific radioactivity of 100-200Ci/g and purified
on talc (Cuatrecasas & Hollenberg, 1976). The
hormone was further purified immediately before use
by gel filtration on a column (1 cm x 25 cm) of BioGel P-10 in Krebs-Ringer phosphate buffer
(Livingston & Lockwood, 1975) prepared without
calcium or magnesium and containing 0.1% (w/v)
bovine serum albumin. Approx. 91% of the radioactivity was located on the A chain of insulin, as
determined by isoelectric focusing after sulphitolysis
(Antoniades et al., 1974) of the radiolabelled
hormone. Rechromatography of the purified 1251labelled insulin gave a single peak of radioactivity
eluted from the Bio-Gel P-10 column
(1.6cm x 100 cm) described below (results not
shown). Radioactivity was determined with a Searle
model 1197 gamma counter.
Degradation of 125I-labelled insulin by intactfatpads, isolated adipocytes and subcellular fractions.
Rats were allowed free access to food before being

B. J. GOLDSTEIN AND J. N. LIVINGSTON

killed by a sharp blow to the head. Two intact epididymal fat-pads were removed by single cuts of their
proximal ends to avoid cellular damage, and the
distal heads were suspended in 4 ml of buffer A
(Krebs-Ringer phosphate buffer, pH 7.4, containing 30mg of bovine serum albumin/ml), containing 125I-labelled insulin (0.5 nM), and incubated in an
atmosphere of 02/C02 (19: 1) at 370C for 90min.
The fat-pads were quickly rinsed with 5 ml of buffer
at room temperature, and rapidly homogenized in
0.8ml of buffer B [4M-urea/lM-acetic acid/0.1%
(v/v) Triton X-1001 (Kahn & Baird, 1978) with a
Dounce homogenizer after being minced with
scissors. The homogenate was centrifuged at
29000g for 30min at 40C. A sample of the supernatant material was then analysed by gel filtration.
Isolated adipocytes were prepared by the collagenase method from the epididymal fat-pads of 12
rats as previously described (Rodbell, 1964). The
cells were washed gently three times with several
volumes of buffer A and diluted 1:3 in buffer A.
Then 5 ml of this suspension was incubated with
0.5 nM-125I-labelled insulin under an atmosphere of
02/CO2 (19: 1) at 370C for 30min. The cells were
centrifuged through 2ml of silicone oil at 1000g for
5 min at room temperature. The cell pellet was dissolved in 1 ml of buffer B and treated as above for
the fat-pad. A sample of the supernatant material
from the cells as well as a portion of the incubation
medium was then analysed by gel filtration.
Alternatively, adipocytes were further washed
twice with several volumes of buffer C [10mMTris/HCl (pH 7.4)/1 mM-EDTA/0.25 M-sucrose]
(Jarett, 1974) after isolation for the preparation of
subcellular fractions. The fractions were prepared
exactly as described by Jarett (1974) by using differential centrifugation and a Ficoll/sucrose discontinuous gradient to purify plasma membranes. The
postmicrosomal supernatant is described in the
present report as cytosol. The nuclear and mitochondrial adipocyte fractions were discarded, since
they have previously been shown to contain insignificant amounts of insulin-degrading activity (Hammond & Jarett, 1975). All cellular materials were
stored at 40C and used within 48 h of preparation.
Adipocyte subcellular fractions were incubated
with 0.5 nM-'251-labelled insulin in buffer A or buffer
D (5mM-EDTA/1OmM-Tris-HCl, pH7.4) containing 30mg of bovine serum albumin/ml at 370C
in a final volume of 0.15 or 0.4 ml. All procedures
were performed with plastic labware. At the
appropriate times, samples were removed for assay
of insulin degradation (see below) or, alternatively,
1 vol. of 2 x buffer B (i.e. double concentrations) was
added to stop the reactions and prepare the sample
for column chromatography.
Characterization of subcellular fractions.
Immediately after preparation, subcellular fractions
1980
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were assayed for marker enzyme activities.
(Na+ + K+ + Mg2+)-stimulated ATPase was measured
as described by McKeel & Jarett (1970), and P1 was
quantified by the method of Hurst (1964). NADHdependent cytochrome c reductase was assayed by
the method of DaUlner et al. (1966). Protein was
measured as described by Miller (1959).

portions of the fat-pa is were carefully suspended in
buffer A to reduce the release of intracellular
degrading activity. After a 90 min incubation of the
fat-pads at 370C with 125I-labelled insulin (0.5nM),
9% of the hormone was destroyed, as measured by
trichloroacetic acid solubility. Of the trichloroacetic
acid-soluble products, approx. 94% were present in
the incubation medium and 6% were found in the
fat-pads. These results have been corrected for the
insulin-degrading activity released, into the incubation medium (Gliemann & Sonne, 1978) in
order to reflect only tissue-derived degradation
products. These findings indicate that the intact fatpad degrades insulin and that the products of degradation rapidly exit the tissue.
Fig. 1 shows a Bio-Gel P-10 gel-filtration pattern
for the 125I-labelled material present in the fat-pads.
Four peaks of radioactivity are evident: a voidvolumn peak (Vo), an insulin-containing peak (Vi,, )
and two peaks of radioactivity at the internal column
volume (V,). It should be noted that primarily
labelled A chain fragments are observed in these
experiments, since the 125I-labelled insulin is prepared with more than 90% of the radioactivity on
the A chain (see under 'Methods'). The radioactivity eluted in the Vi region appears as two incompletely resolved peaks and suggests small-product
heterogeneity. The elution profile for the radioactivity in the incubation medium has the same
major peaks, including the two peaks in the VI region
(results not shown).
A time-dependent accumulation of labelled
material in the V0 peak is consistently observed after

Trichloroacetic acid-solubility assay for insulin
degradation. Degradation of 125I-labelled insulin was
measured by an increase in trichloroacetic acid
solubility of radioactivity in the incubation mixture.
A 50,u1 sample was removed and added to 300,1 of
12% (w/v) trichloroacetic acid at the required time.
Precipitation was allowed to occur at a final bovine
serum albumin concentration of 4mg/ml and 10%
(w/v) trichloroacetic acid, as suggested by Gammeltoft & Gliemann (1973), for 10min at 40C. The
suspension was then transferred to a small plastic
tube and centrifuged at 10000g for 3min in a
Microfuge (Beckman). A portion of the supernatant
radioactivity was counted and compared with a
portion of the initial incubation mixture to calculate
the percentage trichloroacetic acid-soluble radioactivity.
Immunoprecipitation assay for insulin degradation.'25I-labelled-insulin degradation was quantified alternatively by measuring a loss of substrate
immunoreactivity as described by Lomedico &
Saunders (1976), except that 3 mM-N-ethylmaleimide was included in the immunoprecipitation
buffers. The purified 1251-labelled insulin preparation
was 100% immunoprecipitable by this method and
over 97% of the precipitated radioactivity was displaced by excess (10pUM) unlabelled insulin.
Gel filtration of insulin-degradation products.
Column chromatography was performed by applying 0.3-0.6 ml samples from the incubation mixtures
in buffer B to a column (1.6 cm x 100 cm) of Bio-Gel
P-10, and the column developed with buffer B at
room temperature. Fractions of 1.65 or 1.8ml were
collected with upward-flow elution at a rate of
10ml/h, and the radioactivity in each fraction was
determined. Standardization of the column was
performed by using Blue Dextran (V0), 125I-labelled
insulin (Vin), 125I-labelled oxidized insulin A chain
(iodinated by the chloramine-T method) (VA) and
Na25I (V)
Results

Degradation of '251-labelled insulin by the intactfatpad
Studies of insulin degradation were initially
performed in intact fat-pads to circumvent possible
artifacts arising from the collagenase treatment used
in the preparation of isolated adipocytes, a cell
system generally used in studies of insulin action and
insulin degradation (Gliemann & Sonne, 1978; Kahn
& Baird, 1978). In these experiments, the uncut,
Vol. 186
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Fig. 1. Gel-filtration profile of 125I-labelled-insulindegradation products associated with intactfat-pads
Two epididymal fat-pads were incubated with
purified 0.5 nM-'25I-labelled insulin and homogenized as described in the text. After centrifugation, a sample of the supernatant material in
buffer B was subjected to gel filtration on a Bio-gel
P-10 column (1.6cmx 100cm) eluted with buffer
B. Fractions (1.65 ml) were collected at a flow rate
of lOml/h, and the radioactivity in each fraction
was determined.
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incubation of '251-labelled insulin (0.5 nM) at 370C in
buffer A in the absence of cellular degrading activity.
Under these conditions, no label appears to be eluted
after the insulin-containing peak; however, up to
16% of the applied radioactivity may appear in the
V0 after a 60min incubation at 370C.

Studies with isolated adipocytes
The heterogeneity of tissue components present in
an intact fat-pad (Napolitano, 1965) prompted the
investigation of insulin degradation by isolated
adipocytes. A supernatant was prepared from homogenized adipocytes after incubation with '25I-labelled
insulin, and the degradation products were analysed
by gel filtration exactly as described for the fat-pad.
As shown in Fig. 2(a), the major peaks of radioactivity are eluted in positions identical with those in
the profile from the intact fat-pad (Fig. 1); this result
was previously noted for isolated adipocytes
(Gliemann & Sonne, 1978; Kahn & Baird, 1978). In
contrast, the gel-filtration profile of the products
recovered from the incubation medium (Fig. 2b)
demonstrates the presence of several minor peaks
not observed in the profiles from the fat-pad and
which occur in only trace quantities in the profile for
the isolated cells. Further investigation disclosed that
the crude bacterial collagenase used to disperse the
cells contains substantial degrading activity for 125I_
labelled insulin (Fig. 2c). Concentrations of collagenase as low as 2,g/ml render 15% of the 1251labelled insulin (0.5 nM) soluble in trichloroacetic acid
after a 2h treatment at 37°C. This activity is
dependent on enzyme concentration and is not
inhibited by 1 mM-N-ethylmaleimide (results not
shown), which blocks the insulin-degrading activity
of adipose tissue (see Table i). The intermediate
peaks observed in the adipocyte medium (Fig. 2b)
probably originate from contaminating collagenase,
since they are co-eluted with labelled fragments
generated by collagenase alone (Fig. 2c). Furthermore, medium removed from isolated adipocytes
incubated in buffer A demonstrates significant
insulin-degrading activity and a gel-filtration profile
remarkably similar to that obtained with collagenase (results not shown). Substantial contamination due to collagenase components adhering to
the isolated cells has been reported, even after
thorough washing (Salans & Dougherty, 1971).
Because of the presence of this contaminating
activity, it was impossible to assess the rate of
appearance of 1251-labelled-insulin-degradation products in the medium from the isolated adipocytes.
Studies with adipocyte subcellularfractions
Insulin degradation was further studied in subcellular fractions of isolated adipocytes prepared
after the isolated cells had been washed several times
with the homogenization buffer, buffer C. Results for
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Fig. 2. Gel-filtration profiles of 125I-labelled-insulindegradation products
(a) Degradation products associated with isolated
adipocytes. Isolated adipocytes prepared by the
collagenase method were incubated with 0.5 nm251I-labelled insulin in buffer A and then homogenized in buffer B as described in the text. A
portion of the centrifuged homogenate was then
subjected to gel filtration as described in Fig. 1. (b)
The same protocol was used as in (a), except that a
portion of the medium from the adipocyte incubation with 125I-labelled insulin was diluted 1:2 in
2 x buffer B and then subjected to gel filtration as
described in Fig. 1. (c) 1251-labelled-insulin degradation by crude bacterial collagenase. 125I-labelled
insulin (0.5 nM) was incubated for 2h at 370C with
20,ug of crude collagenase in 1 ml of buffer A. The
incubation mixture was then diluted as described in
(b), and subjected to gel filtration as described in
Fig. 1.

the recovery of protein and the two marker enzymes
for the various subcellular fractions are shown in
Table 1. The values for protein recovery closely
1980
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Table 1. Distribution of marker-enzyme activities and proteinfor adipocyte subcellular fractions
Adipocytes were isolated from the epididymal adipose tissue of 12 rats weighing 220-240g, and subcellular
fractions were prepared and used immediately to assay marker-enzyme activities as described in the text. Values
represent means + S.E.M. for three separate experiments. ATPase activity is expressed as nmol of P1 released/lOmin
per mg of protein; reductase activity is given as nmol of cytochrome c reduced/min per mg of protein.
Enzyme activity
Total protein
(Na+ + K+ + Mg2+)-ATPase
Fraction
NADH-cytochrome c reductase
(mg)
Homogenate
140± 14
83±3
600±40
13±5
12+3
Cytosol
43±2
1.0+ 0.2
Plasma membranes
760 ± 90
650± 200
2.0+0.2
130+5
Microsomal
3100± 150

Table 2. 125I-labelled-insulin degradation in adipocyte subcellularfractions
Adipocyte subcellular fractions were prepared as described in the text and used at the protein concentration
indicated in the assay for insulin degradation. 125I-labelled-insulin degradation is expressed as the percentage of the
radioactivity of the labelled hormone (0.5nM) soluble in trichloroacetic acid (10%, w/v) after a 30min incubation in
buffer A at 370C; results are given as means+ S.E.M. for the numbers of experiments in parentheses. Values for
the total insulin-degrading activity of the fraction are calculated from the degradation rates given in this Table and
the protein determinations for each fraction presented in Table 1. Data are given as pmol of insulin degraded after
30min at 370C measured by the trichloroacetic acid-solubility method, and the values represent means ± S.E.M.,
incorporating the errors for each separate calculation.
Total
125I-labelled-insulin
Fraction
degradation
activity
10.8 + 1.0 (4)
23.2 + 3.0
Homogenate (200,ug/ml)
24.9 ± 2.8 (4)
26.8+ 4.3
Cytosol (200,ug/ml)
0.7 +0.1 (4)
0.035 + 0.012
Plasma membranes (l00,ug/ml)
2.2 ± 0.4 (3)
0.220+0.062
Microsomal (l00pug/ml)
0.2+0.1 (4)
Cytosol (200#ug/ml) + N-ethylmaleimide (1 mM)
36.8 + 3.7 (4)*
Cytosol (200,ug/ml)+ plasma membranes (l OO,g/ml)
P <0.01 by paired t analysis
performed separately.
*

versus

the

agree with those reported by Jarett (1974). The
of
enrichment
plasma
membranes
for
(Na+ + K+ + Mg2+)-stimulated ATPase activity is
approx. 5-fold over both the homogenate and the
microsomal fraction. Similarly, NADH-cytochrome c reductase activity is enriched approx. 5and 4-fold in the microsomal fraction over the
homogenate and the plasma-membrane fraction
respectively. These values are in close agreement
with those reported for similar fractions prepared by
linear (McKeel & Jarett, 1970) or discontinuous
(Jarett, 1974) Ficoll/sucrose gradients.
Among the three fractions studied, more than
99% of the total 125I-labelled-insulin-degrading activity, as measured by the trichloroacetic acid-solubility method, is present in cytosol (Table 2). The
insulin-degrading activity present in the cytosol
fraction is completely inhibited by 1 mM-N-ethylmaleimide (Table 2) and therefore cannot be attributed to N-ethylmaleimide-resistant proteinases
from the collagenase treatment. The specific radioactivity of 125I-labelled insulin degradation (percentage degraded/mg of protein) is 5.7 times higher in
the cytosol than in the microsomal fraction, which
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sum

of the cytosol and plasma-membrane incubations

agrees with the value reported previously for this
tissue (Hammond & Jarett, 1975). However, very
little degrading activity is found in the plasmamembrane fraction (Table 2).
Purified

plasma

membranes

of

adipocytes

are

known to contain the bulk of cellular insulin-binding
activity (Hammond & Jarett, 1975). To assess the
effects of the insulin receptor on insulin degradation,
plasma membranes were added to cytosol and
insulin degradation was assayed by the trichloroacetic acid-solubility method. As shown in Table 2,
the presence of plasma membranes increases cytosol
insulin degradation by 45%. Under these conditions,
insulin degradation is linear for at least 30min. This
potentiation of cytosol insulin degradation is dependent on the amount of plasma membranes present;
the effect is saturated when 200,g of membrane
protein is added to 200,pg of cytosol in a 1 ml assay
(results not shown).
Degradation of '25I-labelled insulin by the plasmamembrane and cytosol fractions was further studied
by gel filtration of the degradation products on BioGel P-10 (Fig. 3). In agreement with the previous
studies in which degradation was measured by tri-
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Table 3. 125I-labelled-insulin degradtion by plasma
membranes in the presence of 2 mM-GSH
Incubations were performed at 370C for 90min in
buffer D containing 0.5nM-125I-labelled insulin and
30mg of bovine serum albumin/ml. A sample was
analysed by gel filtration as described in Fig. 3.
Plasma membranes were incubated at a protein
concentration of 160,g/ml.
Percentage of total radioactivity
in each peak

VA
V0

co

w8E 06

VOo
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Fig. 3. Gel-filtration profiles of'25I-labelled-insulin-degradation products from adipocyte subcellular fractions
(a) Plasma membranes (35 pg of protein) were
incubated at 37°C for 30min with 1251-labelled
insulin (0.5 nM) in 0.5 ml of buffer A. Then 1 vol. of
2 x buffer B was added, and a sample of this
material was analysed by gel filtration as described
in Fig. 1. (b) The same protocol was used as in (a)
except that the incubations contained either lOO,ug
of cytosol protein (x) or lOO,ug of cytosol protein
with 50,ug of membrane protein (0) in a 0.5 ml
volume; the same amount of radioactivity was
applied to the column for both experiments; therefore areas under the peaks are representative of the
percentage of total radioactivity eluted in that
position for each experiment.

chloroacetic acid solubility, the plasma membranes
alone are found to destroy only a trace amount of
labelled insulin. In contrast, cytosol alone causes
extensive destruction of 1251-labelled insulin. Besides
the degradation products eluted in the V0 and
V,, the cytosol produces fragments with peaks of
radioactivity eluted in the position of the A chain
and in the region between the insulin and the Achain peaks. These two components do not appear
in the elution profiles from the intact adipocytes
or fat-pad (Figs. 1 and 2).
Although an increase in trichloroacetic acidsoluble products is observed by incubating plasma
membranes with cytosol, this effect is not caused by
an increase in the destruction of intact insulin. As
shown in Fig. 3(b), the amount of radioactivity in the
insulin peak is the same in the presence or absence of

membranes; also, the size of the V0 peak is
comparable with or without plasma membranes.
Therefore the effect of plasma membranes is to accelerate the degradation of the intermediate peak
(eluted between V,n, and VA), which leads to an
increase in the amount of low-molecular-weight (V,)
products.
To investigate the possibility that the adipocyte
plasma membrane contains an enzyme with
glutathione-insulin transhydrogenase activity as
reported for liver (Varandani, 1973), plasma membranes were incubated with 1251-labelled insulin and a
physiological concentration of GSH (2 mM) (Goldstein & Livingston, 1978). As indicated in Table 3
and as previously described (Hird, 1962), GSH itself
has significant activity in reducing insulin to labelled
material eluted in the VA region of the gel-filtration
column. However, plasma membranes greatly accelerate this reductive cleavage (Table 3), but under
these conditions, no further degradation products of
the A chain are observed (results not shown).
The degradation of '251-labelled insulin by the
microsomal fraction produces labelled material that
is eluted in the position of the A chain and a smaller
peak that appears shortly after the A chain (Fig. 4).
Microsomal fractions are therefore similar to
cytosol, since they digest insulin to intermediates
that are not observed in the intact tissue. It is
important to note that degradation products do not
appear in the internal column volume, which is
similar to the results obtained with plasma membranes. However, the substantial amount of degradation products located in the VA position clearly
differentiates the degradative activity of the microsomal fraction from that of plasma membranes.
Results with dialysed cytosol
The effect of dialysis on the insulin-degrading
activity of adipocyte cytosol was studied to determine if this activity is dependent on a diffusible
factor such as GSH. Preparation of the dialysis
tubing by the usual EDTA treatment leads to a significant loss of degrading activity, as assessed by
1980
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Table 4. Effect ofdialysis and GSH on 125I-labelled-insulin degradation
Incubations were performed at 370C for 30min in buffer A with 0.5nM-'25I-labelled insulin and cytosol protein
at 200,g/ml (trichloroacetic acid-solubility assay) and lOO,ug/ml (immunoprecipitation assay); where included,
membrane protein was 160 and 80,ug/ml for the two assays respectively. Values are corrected for backgrounds
in the absence and presence of GSH (2mM), and represent the means of two experiments. Dialysis was carried
out with 2ml of the cytosol from the fractionation procedure against 1 litre of buffer C at 40C for 24h with two
changes. The dialysis tubing was treated, to remove sulphur compounds, with 0.3% Na2S at 800C for I min, and
washed with water and 0.2% H2SO4 before equilibration with buffer C.
125I-labelled insulin degraded (%)
Incubation
Cytosol
Cytosol + GSH
Dialysed cytosol
Dialysed cytosol + GSH
Plasma membranes
Cytosol + plasma membranes
Dialysed cytosol + plasma membranes
-a
5

VA...
10

E

8
.

6
4

x
x

V.

VA

VO

I

I

I

2

01
0

20

40

60

80

100

Fraction no.

Fig. 4. Gel-filtration profile of 125I-labelled-insulindegradation productsfrom adipocyte microsomalfraction
Adipocyte microsomal fraction (66,ug of protein)
was incubated for 60min at 370C with 125I-labelled
insulin (0.5 nM) in 0.4 ml of buffer A. A sample was
prepared and gel filtration was performed as
described in Fig. 3(a).

either method (results not shown). However, when
the tubing is treated with sulphide to remove sulphur
compounds, no such loss of activity occurs (Table
4). These results suggest that the cytosol enzyme(s)
is not dependent on a diffusible factor for activity,
and that the enzyme(s) is sensitive to sulphurous
contaminants on the dialysis tubing.
The effects of GSH on the degradation of insulin
by cytosol are complex and difficult to interpret.
There is clearly a difference in the results depending
on which method is used to assess insulin destruction. For example, the addition of GSH to the
undialysed cytosol inhibits the formation of trichloroacetic acid-soluble products, but potentiates
insulin destruction when measured by immunoprecipitation (Table 4). Dialysed cytosol responds to
GSH treatment in a similar manner to the undialysed material, suggesting that GSH is not an
Vol. 186

Trichloroacetic acidsolubility assay
16.2
10.8
15.5
8.8
1.2
27.9
29.3

Immunoprecipitation
28
35
35
36
7.5
35
39

important participant in the degradation of insulin
by this cell compartment.
The immunoprecipitation method for assessing
insulin degradation also shows that the addition of
plasma membranes to cytosol does not potentiate
the destruction of intact insulin (Table 4). Since
immunoprecipitation measures the amount of intact
insulin remaining, this observation confirms the data
in Fig. 3(b), i.e. plasma membranes do not potentiate the degradation of native insulin, only those
fragments of 125I-labelled insulin first produced in the
cytosol.
Discussion
The cellular degradation of circulating proteins
including polypeptide hormones is a complex and
poorly understood phenomenon (Bohley et al.,
1970; Ballard, 1977). This process may in some
cases be receptor-initiated (Neville & Chang, 1978),
and movement to specific intracellular degrading
sites may occur (Katunuma et al., 1975). However,
although insulin can move into target cells after
interacting with the receptor (Schlessinger et al.,
1978), it is not clear whether the degradation of
insulin follows a designated pathway or whether a
variety of proteinases act randomly to destroy the
hormone.
There is also difficulty in interpreting the findings
from previous insulin-degradation studies. Differences in the methods used to quantify the amount
of degradation, the conditions under which the
studies were conducted (buffer composition, nonphysiological hormone concentrations etc.) and the
type of cell preparation (whole tissue, isolated cell
and subcellular fraction) all can contribute to
produce artifacts and contradictory findings. To help
alleviate these problems, insulin degradation by
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adipocytes was systematically studied in the present
investigation at the organ level (i.e. fat-pad), and in
isolated adipocytes and subcellular fractions, with
the use of physiological hormone concentrations and
three different methods to assess hormonal destruction.
The intact fat-pad degrades insulin and produces
products of two sizes, one of which is eluted in the
void volume of the Bio-Gel P-10 column. The other
products are small and are eluted as two overlapping peaks in the internal volume. Only these
same products are found in the incubation buffer,
which contains the vast majority of degraded
material. The V0 material is observed in the absence
of cellular material and therefore may not be physiologically significant (see below). Insulin fragments
the size of the A chain are not observed; if they
occur, their half-life in the tissue must be extremely
short. Also, the studies on the fat-pad indicate that
the tissue does not accumulate the products of
degradation, which appear to be rapidly ejected from
the cells. This has previously been suggested for
isolated adipocytes (Gliemann & Sonne, 1978).
Insulin degradation by this cell preparation resulted
in the same products as were found with the fat-pad.
in addition, other insulin fragments were found in
the incubation medium; however, these products
appeared to result from the action of proteinases that
contaminate the cell preparation as a consequence of
the treatment with crude collagenase (Salans &
Dougherty, 1971). Thus no cell-derived products of
intermediate size were found, which again suggests
the presence of a highly efficient mechanism responsible for insulin degradation.
To investigate the cellular mechanisms comprising this efficient degrading system, subcellular
fractions prepared from isolated adipocytes were
examined to determine their abilities to degrade the
hormone. In the absence of GSH, almost all the
degrading activity in the crude homogenate is
present in the cytosol fraction (99%; Table 2). The
microsomal fraction destroyed insulin at a much
higher rate than the plasma membranes, although
the microsomal activity was very small compared
with that of the cytosol fraction. In the presence of
GSH, the membrane fraction was able to degrade
more insulin. However, considering the quantity of
total activity recovered in the cytosol fraction,
membrane degradation is overall a small percentage
of the cellular degrading capacity. GSH does not
stimulate degradation by the adipocyte cytosol, in
agreement with previous findings (Hammond &
Jarett, 1975).
Gel-filtration studies demonstrated that the
cytosol and microsomal fractions generate fragments of insulin, which are not observed in the fatpad or isolated adipocytes. One of the fragments is
eluted in the position of insulin A chain and the other

B. J. GOLDSTEIN AND J. N. LIVINGSTON

is eluted between the A chain and insulin. These
'new' intermediate-sized insulin fragments occur as
initial degradation products in the adipocyte cytosol.
In the intact cell or tissue, these fragments are not
observed, suggesting that they have a transient intracellular existence.
A possible explanation for the short half-life of the
intermediate-sized insulin fragments generated in
cytosol is provided by the effects of plasma membranes on the cytosol degrading ability. Although
membranes did not appear to contribute significantly to the initial degradation of the hormone, they
did enhance the ability of the cytosol to degrade the
intermediate-sized fragments to the small products
found in the internal volume (Fig. 3). This enhancement was also shown by the increase in trichloroacetic acid-soluble fragments produced by the
combination of plasma membranes with cytosol. In
these experiments, the amounts of labelled insulin
fragments eluted at the internal column volume
correlated directly with the trichloroacetic acidsoluble radioactivity (results not shown). The plasma
membranes were also unable to increase the appearance of trichloroacetic acid-soluble products in
cytosol when the cytosol degrading activity was
dialysed in EDTA-treated dialysis tubing, a
manoeuvre that destroys the insulin-degrading
ability of cytosol (results not shown). Therefore it is
possible that the plasma membrane acts on a
fragment of insulin that is slightly larger than the
insulin A chain, which is generated in the cytosol;
this action further degrades it to the products eluted
at the internal column volume. These findings
suggest the existence of a co-operative mechanism
between the plasma membrane and cytosol for the
rapid and highly efficient degradation of insulin to
small products. The location of this activity on the
plasma membrane may help explain the rapid release
of these small products from the cell.
The biological relevance of these degradation
products is not known. It has been observed that
synthetic peptides with homology to sequences on
the insulin B chain possess insulin-like activity
(Fujino et al., 1977; Weitzel et al., 1971, 1973).
Furthermore, one such fragment has been shown to
potentiate the actions of insulin in adipose tissue
(Fujino et al., 1977). Kahn & Baird (1978) have
proposed that the high-molecular-weight material
eluted in the void volume may represent a biologically important association of insulin with the insulin
receptor or with other cellular components.
However, we observe a time-dependent accumulation of this product in the absence of any cellular
material, suggesting that it is not physiologically
related to insulin metabolism in adipocytes.
Although adipocytes and subcellular fractions
caused a marked increase in the void-volume
material, this may simply represent covalent com-
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plexes formed by thiol exchange as the hormone is
reductively cleaved (Mahbouba & Smith, 1977). We
find that after sulphitolysis most of the radioactivity
from this peak migrates as S-sulphonated A chain
during isoelectric focusing (results not shown),
indicating that it may consist of intact insulin chains
linked as disulphides in a high-molecular-weight
aggregate (Varandani et al., 1972; Antoniades et al.,
1974).
The results of the present study suggest that
adipocyte subcellular compartments may act in
sequence to cleave insulin. Although some degradation of the hormone may occur at the plasma
membrane, it appears to enter the cell or in some
manner gain access to cytoplasmic enzymes, which
produce the bulk of hormone degradation. In fact,
the cytosol is the only subcellular adipocyte fraction
capable of degrading insulin to the low-molecularweight material that is observed as the major
product of insulin degradation in the intact tissue.
The movement of insulin to an intracellular compartment in adipocytes may involve the insulin receptor
or the formation of pinocytotic vesicles at the
surface of the cell (Barrnett & Ball, 1960). However,
the receptors or other plasma-membrane structures
do not appear to be involved with the direct degradation of insulin, since the addition of membranes to
cytosol does not increase the initial destruction of
insulin. Also, it has been demonstrated in our
laboratory that the insulin-degrading activity of liver
membranes can be separated from the binding
activity of the insulin receptor (Livingston & Krupp,
1978). Furthermore, experiments with adipocyte
plasma membranes demonstrate that detergent-solubilized material containing the insulin receptor does
not degrade insulin (Krupp & Livingston, 1978). It
seems clear therefore that, in the adipocyte, insulin
destruction is carried out to a large extent by cytoplasmic factors.
The plasma membrane appears to participate in
the further processing of the initial (intermediatesized) fragments of insulin that are generated in the
adipocyte cytosol. This co-operation enhances that
ability of the recombined subcellular fractions to
degrade insulin further to small peptides and/or
amino acids, which are observed as the only degradation products in the intact tissue. Some evidence
of synergism for the production of trichloroacetic
acid-soluble products from insulin has also been
observed between a high-speed supernatant and a
particulate fraction from the rat kidney (Duckworth,
1976).
In conclusion, insulin degradation by adipocytes
may occur as an ordered process whereby fragments
produced by one subcellular fraction are subsequently degraded further by another cellular compartment. The low-molecular-weight products are
then rapidly released into the surrounding medium
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and are not accumulated by the cell. These results
offer some insight into the cellular processes acting
to degrade insulin. It is also possible that similar
mechanisms are involved in the intracellular degradation of other circulating proteins.
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